Targeting tumour re-wiring by triple blockade of mTORC1, epidermal growth factor and estrogen receptor signalling pathways in endocrine resistant breast cancer
收藏NIAID Data Ecosystem2026-03-11 收录
下载链接：
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE112401
下载链接
链接失效反馈官方服务：
资源简介：
Our data supports the potential combination of inhibition of ERBB2/3 signalling with mTORC1 perturbation and endocrine therapy in patients who have relapsed on endocrine therapy and retain a functional ER. RNAseq examination of gene expression changes in MCF72a-LTED tumour xenografts due to treatment with RAD001 (RAD), the pan-ERBB inhibitor neratinib (Ner) and fulvestrant ICI182780 (Ful)
创建时间：
2019-03-27
